Study Comparing 3 New Formulations of Premarin® 0.625 mg/MPA 2.5 mg With a Reference Formulation
Clinical trial NCT00630435 · COMPLETED
Trial details
- NCT number
- NCT00630435
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-01
- Primary completion
- 2008-06-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.